REQUEST A DEMO
Total
USD $0.00
Search more companies

Gestion Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gestion Pharma S.A.S. Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Gestion Pharma S.A.S. is an enterprise in Colombia, with the main office in Cartagena. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on November 27, 2003. 40 (2023) employees currently work for Gestion Pharma S.A.S.. In 2022, the company reported a net sales revenue increase of 15%. Its total assets grew by 15.99% over the same period. The net profit margin of Gestion Pharma S.A.S. increased by 3.73% in 2022.

Headquarters
Carrera 40 27 49 Barrio Amberes
Cartagena; Bolivar;

Contact Details: Purchase the Gestion Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Gestion Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Gestion Pharma S.A.S. report to view the information.
Incorporation Date:
November 27, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Gestion Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15%
Total operating revenue
15.92%
Operating profit (EBIT)
136.47%
Net Profit (Loss) for the Period
169.07%
Total assets
15.99%
Total equity
32.37%
Operating Profit Margin (ROS)
5.8%
Net Profit Margin
3.73%
Return on Equity (ROE)
12.42%
Quick Ratio
0.35%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?